AVVie GmbH
Verified IntelMore than 8 million people in Europe and the US suffer from moderate to severe mitral valve regurgitation (blood leaking back into the heart´s left atrium). If left untreated, this condition may ultimately lead to heart failure. Open-heart surgery is the current gold-standard for treating mitral valve prolapse. Due to significant procedure risks for the patients, up to 50% of the affected population are left untreated. The Mitral Butterfly implant is based on a unique physiological design that can be deployed in one-step. Transcatheter implantation provides for a minimally invasive procedure.
More than 8 million people in Europe and the US suffer from moderate to severe mitral valve regurgitation (blood leaking back into the heart´s left atrium). If left untreated, this condition may ultimately lead to heart failure. Open-heart surgery is the current gold-standard for treating mitral valve prolapse. Due to significant procedure risks for the patients, up to 50% of the affected population are left untreated. The Mitral Butterfly implant is based on a unique physiological design that can be deployed in one-step. Transcatheter implantation provides for a minimally invasive procedure.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Medical Devices
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 11-50
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Vienna Vienna
- City
- Vienna
- Region / State
- Wien
- Postal Code
- 1090
- Country
- Austria
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for AVVie GmbH.